RhumbLine Advisers’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-15,258	Closed	-$352K	–	3054
2020 Q4	$352K	Buy	15,258 +1,050	+7%	+$24.2K	﹤0.01%	2598
2020 Q3	$145K	Sell	14,208 -808	-5%	-$8.25K	﹤0.01%	2783
2020 Q2	$224K	Buy	+15,016	New	+$224K	﹤0.01%	2721